Determination of the Optimum Cut-off Value of Type 2 Diabetes Diagnosis Among Chinese Population(SENSIBLE STUDY II)

Determination of Cut-off Value of Advanced Glycation End-product and Glycosylated Haemoglobin in Type 2 Diabetes Diagnosis in China

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03024788

Enrollment

6000

Registered

2017-01-19

Start date

2017-01-31

Completion date

2020-12-31

Last updated

2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type II Diabetes

Keywords

Glycosylated haemoglobin, advanced glycation end products

Brief summary

Study of the correlation between AGEsP and HbA1c and diabetic retinopathy prevalence: determination of cut-off value of AGEsP and HbA1c in type 2 diabetes diagnosis in China

Detailed description

To find the cut-off point of AGEsP and HbA1c for diagnosis of diabetes by drawing the logistic regression model between prevalence of retinopathy and AGEsP level and HbA1c level,and find the point where the prevalence of retinopathy changes most rapidly.

Interventions

DEVICEsyringe, fundus camera etc

Physical examination, fundus examination, blood and urine samples collection

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Yes

Inclusion criteria

* 20\ 70 years old; * Volunteer to participate in this study and signed informed consent.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame	Description
prevalence of retinopathy	3 years	the prevalence of retinopathy in different AGEsP and HbA1c levels

Secondary

Measure	Time frame	Description
incidence of retinopathy	3 years	incidence of retinopathy in different AGEsP and HbA1c levels

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026